Taho Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016	2011 - 2015
Period Ending	Oct '25 Oct 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	2011 - 2015
Market Capitalization	10,021	2,274	-	-	616	549	Upgrade
Market Cap Growth	2636.65%	-	-	-	12.10%	-59.61%	Upgrade
Enterprise Value	9,634	2,074	-	-	430	279	Upgrade
Last Close Price	195.00	44.35	-	-	11.76	10.49	Upgrade
PS Ratio	1288.23	-	-	-	49.65	15.25	Upgrade
PB Ratio	22.48	4.41	-	-	3.55	1.76	Upgrade
P/TBV Ratio	22.52	4.41	-	-	3.94	1.89	Upgrade
EV/Sales Ratio	-	-	-	-	34.70	7.75	Upgrade
Debt / Equity Ratio	0.03	0.03	0.11	-	0.01	0.00	Upgrade
Asset Turnover	0.02	-	0.01	-	0.05	0.09	Upgrade
Inventory Turnover	-	-	-	-	2.18	2.02	Upgrade
Quick Ratio	35.53	15.02	3.85	2.29	5.13	19.17	Upgrade
Current Ratio	35.74	15.09	3.91	2.39	5.70	20.53	Upgrade
Return on Equity (ROE)	-48.14%	-46.32%	-80.79%	-	-56.44%	-29.72%	Upgrade
Return on Assets (ROA)	-29.12%	-25.20%	-35.89%	-	-25.53%	-17.73%	Upgrade
Return on Capital (ROIC)	-29.66%	-27.94%	-47.25%	-	-27.51%	-18.50%	Upgrade
Earnings Yield	-1.66%	-7.36%	-	-	-22.27%	-19.88%	Upgrade
FCF Yield	-1.72%	-7.29%	-	-	-22.48%	-18.79%	Upgrade
Buyback Yield / Dilution	-17.82%	-17.18%	-7.73%	31.26%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.